
| Pair Name | Ginger extract, Doxorubicin | ||
| Phytochemical Name | Ginger extract (PubChem CID: / ) | ||
| Anticancer drug Name | Doxorubicin (PubChem CID: 31703 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Ginger extract, Doxorubicin | |||
| Disease Info | [ICD-11: 2A00-2F9Z] | Solid tumour or cancer | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Down-regulation | Expression | NFKB1 | hsa4790 |
| Up-regulation | Expression | TP53 | hsa7157 | |
| Down-regulation | Expression | CCND1 | hsa595 | |
| Up-regulation | Phosphorylation | PRKAA1 | hsa5562 | |
| In Vivo Model | 1×10⁶ EAC cells were implanted subcutaneously into the right thigh of the lower limb of mice. | |||
| Result | AMPK pathway and cyclin D1 gene expression could be a molecular therapeutic target for the anticancer effect of GE in mice bearing SEC. Combining GE and DOX revealed a greater efficacy as anticancer therapeutic regimen. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms. Eur J Nutr. 2018 Apr;57(3):981-989. doi: 10.1007/s00394-017-1382-6. | Click |